AAAAAA
Results:
1-12
|
Results: 12
Authors:
FABI A
MAGNANI E
GAMUCCI T
DALESSIO A
MAZZA D
RAMBONE R
SARACINO B
COGNETTI F
Citation: A. Fabi et al., PREOPERATIVE COMBINATION OF CONCOMITANT RADIOTHERAPY AND CISPLATIN (CDDP) PLUS FLUOROURACIL (FU) GIVEN BY CONTINUOUS INTRAVENOUS-INFUSION (CIVI) IN LOCALLY ADVANCED CERVICAL-CANCER (LACC), Annals of oncology, 9, 1998, pp. 335-335
Authors:
OBERHOFF C
NERI B
AMADORI D
PETRY KU
GAMUCCI T
REBMANN U
NOWROUSIAN MR
VOIGTMANN R
MONFARDINI S
ARMAND JP
HERRMANN R
NETTERPINON J
TUBIANAMATHIEU N
ZWIERZINA H
Citation: C. Oberhoff et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS - A RANDOMIZED, CONTROLLED-STUDY, Annals of oncology, 9(3), 1998, pp. 255-260
Authors:
PARIDAENS R
BRUNING P
KLIJN J
GAMUCCI T
BIGANZOLI L
VANVRECKEM A
BOES GH
CURRAN D
PICCART M
Citation: R. Paridaens et al., TAXOL (T) VERSUS DOXORUBICIN (D) AS FIRST-LINE CHEMOTHERAPY (CT) IN ADVANCED BREAST-CANCER (ABC) - AN EORTC RANDOMIZED STUDY WITH CROSSOVER, European journal of cancer, 33, 1997, pp. 645-645
Authors:
ARDIZZONI A
HANSEN H
DOMBERNOWSKY P
GAMUCCI T
KAPLAN S
POSTMUS P
GIACCONE G
SCHAEFER B
WANDERS J
VERWEIJ J
Citation: A. Ardizzoni et al., TOPOTECAN, A NEW ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PATIENTS WITH REFRACTORY AND SENSITIVE DISEASE, Journal of clinical oncology, 15(5), 1997, pp. 2090-2096
Authors:
DIRIX LY
TONNESEN F
CASSIDY J
EPELBAUM R
HUININK WWT
PAVLIDIS N
SORIO R
GAMUCCI T
WOLFF I
TEVELDE A
LAN J
VERWEIJ J
Citation: Ly. Dirix et al., EO9 PHASE-II STUDY IN ADVANCED BREAST, GASTRIC, PANCREATIC AND COLORECTAL-CARCINOMA BY THE EORTC EARLY CLINICAL-STUDIES GROUP, European journal of cancer, 32A(11), 1996, pp. 2019-2022
Authors:
PAVLIDIS N
HANAUSKE AR
GAMUCCI T
SMYTH J
LEHNERT M
TEVELDE A
LAN J
VERWEIJ J
Citation: N. Pavlidis et al., A RANDOMIZED PHASE-II STUDY WITH 2 SCHEDULES OF THE NOVEL INDOLOQUINONE-EO9 IN NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE EORTC EARLY CLINICAL-STUDIES GROUP (ECSG), Annals of oncology, 7(5), 1996, pp. 529-531
Authors:
PICCARTGEBHART MJ
BRUNING P
GAMUCCI T
KLIJN J
ROY JA
AWADA A
KUSENDA Z
VANVRECKEM A
PARIDAENS R
Citation: Mj. Piccartgebhart et al., AN ONGOING EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCERCROSSOVER TRIAL COMPARING SINGLE-AGENT PACLITAXEL AND DOXORUBICIN AS FIRST-LINE AND SECOND-LINE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 11-15
Authors:
ARDIZZONI A
HANSEN HH
DOMBERNOWSKY P
KAPLAN S
POSTMUS PE
GAMUCCI T
SCHAEFER B
WANDERS J
VERWEIJ J
Citation: A. Ardizzoni et al., PHASE-II STUDY OF TOPOTECAN IN REFRACTORY AND SENSITIVE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 31A, 1995, pp. 84-84
Authors:
GAMUCCI T
CALABRESI F
ZEULI M
CERIBELLI A
COLUCCI G
LOMEO A
MALUTA S
BATTELLI T
BIANCO R
BREMA F
GHEZZI P
MAJOLI I
Citation: T. Gamucci et al., PREVENTION OF ANEMIA IN CANCER-PATIENTS TREATED WITH CISPLATIN-CONTAINING CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 239-239
Authors:
WANDERS J
PAVLIDIS N
GAMUCCI T
HUININK WWT
DIRIX L
WOLFF I
VERWEIJ J
Citation: J. Wanders et al., PHASE-II STUDIES WITH EO9 IN BREAST, COLORECTAL, GASTRIC, PANCREATIC AND NSCLC, European journal of cancer, 31A, 1995, pp. 565-565
Authors:
CREEMERS GJ
WANDERS J
GAMUCCI T
VALLENTIN S
DIRIX LY
SCHOFFSKI P
HUDSON I
VERWEIJ J
Citation: Gj. Creemers et al., TOPOTECAN IN COLORECTAL-CANCER - A PHASE-II STUDY OF THE EORTC EARLY CLINICAL-TRIALS GROUP, Annals of oncology, 6(8), 1995, pp. 844-846
Authors:
CALABRESI F
GAMUCCI T
Citation: F. Calabresi et T. Gamucci, BIOLOGICAL RESPONSE MODIFIERS, Lung cancer, 12, 1995, pp. 193-198
Risultati:
1-12
|